Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infiltration of Upper Cluneal Nerves in Cluneal Syndrome
NCT05423132Withdrawn
- Sponsor
- Saint-Pierre University Hospital
- Start
- Jun 2022
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of ropivacaine in cluneal nerve entrapment syndrome (CNES) (2 arms), sponsored by Saint-Pierre University Hospital. Primary endpoint: Reduction of pain intensity in the acute phase of the treatment at 1 hour. Planned start Jun 2022; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
cluneal nerve entrapment syndrome (CNES)
Beyond the preview
Go deeper on NCT05423132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05423132.